Olmetec

Olmetec

olmesartan

Manufacturer:

Daiichi Sankyo

Distributor:

Pfizer
Concise Prescribing Info
Contents
Olmesartan medoxomil
Dosage/Direction for Use
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Do not co-administer w/ aliskiren in patients w/ diabetes. Pregnancy.
Special Precautions
Symptomatic hypotension may occur in vol- &/or Na-depleted patients. Patients w/ bilateral renal artery stenosis. Sprue-like enteropathy. Monitor serum electrolytes periodically. Renal impairment. Pregnancy & lactation. Childn.
Drug Interactions
Increased serum conc & toxicity of lithium. Increased risk of hypotension, hyperkalemia & changes in real function including acute renal failure w/ angiotensin receptor antagonist, ACE inhibitors or aliskiren. May increase risk of worsening renal function w/ NSAIDs. Attenuated antihypertensive effect w/ NSAIDs including COX2 inhibitors. Reduced systemic exposure & peak plasma conc w/ colesevelam HCl.
MIMS Class
Angiotensin II Antagonists
ATC Classification
C09CA08 - olmesartan medoxomil ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Olmetec FC tab 10 mg
Packing/Price
30's (P1,298.67/pack)
Form
Olmetec FC tab 20 mg
Packing/Price
30's (P1,528.09/pack)
Form
Olmetec FC tab 40 mg
Packing/Price
30's (P2,403.91/pack)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in